首页> 外文期刊>The Lancet >The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine.
【24h】

The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine.

机译:与口服舒马曲坦相比,口服赖氨酸乙酰水杨酸盐和甲氧氯普胺联合治疗偏头痛的有效性。

获取原文
获取原文并翻译 | 示例
       

摘要

Aspirin is commonly used to treat migraine attacks, although sumatriptan, a much more expensive treatment, is also effective. We compared a combination of lysine acetylsalicylate (equivalent to 900 mg aspirin) and 10 mg metoclopramide (LAS+MTC) with oral sumatriptan (100 mg) and placebo in 421 patients with migraine. LAS+MTC was as effective as sumatriptan with a decrease of headache from severe or moderate to mild or none of 57% and 53%, respectively, for the first migraine attack treated. Both treatments were better than placebo (success rate 24%, p < 0.0001). LAS+MTC was significantly more effective in the treatment of nausea than sumatriptan (p < 0.0001) and was better tolerated (adverse events in 18% and 28%, respectively, p < 0.05). LAS+MTC is as effective as sumatriptan in the treatment of migraine attacks. It is also much cheaper.
机译:阿司匹林通常用于治疗偏头痛,尽管舒马普坦(一种更昂贵的治疗方法)也有效。我们在421例偏头痛患者中比较了赖氨酸乙酰水杨酸酯(相当于900 mg阿司匹林)和10 mg甲氧氯普胺(LAS + MTC)与口服舒马曲坦(100 mg)和安慰剂的组合。 LAS + MTC与舒马普坦一样有效,在治疗的首例偏头痛发作中,头痛从重度或中度降低至轻度或分别减轻了57%和53%。两种治疗均优于安慰剂(成功率24%,p <0.0001)。 LAS + MTC在治疗恶心方面比舒马普坦更有效(p <0.0001),耐受性更好(不良事件分别为18%和28%,p <0.05)。 LAS + MTC在治疗偏头痛发作方面与舒马普坦一样有效。它也便宜得多。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号